Despite the 3xTg-AD we used in these previous studies shows similar distribution of Aβ and Tau alterations present in human AD and demonstrates synaptic dysfunction with impaired long-term potentiation (LTP; Oddo et al. 2003), the interpretations of these studies are limited since these are not performed in human pathological samples. The gene discussed is MAPT; the disease is Alzheimer disease.